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Histone deacetylaseThe nuclear receptor NOR1 is an immediate-early response gene implicated in the transcriptional
control of proliferation. Since the expression level of NOR1 is rapidly induced through cAMP
response element binding (CREB) protein-dependent promoter activation, we investigated the con-
tribution of histone acetylation to this transient induction. We demonstrate that NOR1 transcription
is induced by histone deacetylase (HDAC) inhibition and by depletion of HDAC1 and HDAC3. HDAC
inhibition activated the NOR1 promoter, increased histone acetylation and augmented the recruit-
ment of phosphorylated CREB to the promoter. Furthermore, HDAC inhibition increased Ser133
phosphorylation of CREB and augmented NOR1 protein stability. These data outline previously
unrecognized mechanisms of NOR1 regulation and illustrate a key role for histone acetylation in
the rapid induction of NOR1.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The neuron-derived orphan receptor-1 (NOR1) is an
evolutionarily conserved member of the ligand-independent
NR4A subfamily of the nuclear hormone receptor superfamily [1].
Members of this subfamily serve as immediate-early response
genes to translate environmental cues into transcriptional
programs of gene expression [2]. Being early response genes, the
transcriptional activity of NR4A nuclear receptors is regulated by
their rapid and transient expression as well as by posttranslational
protein modiﬁcation of the receptor [3,4]. Although still in its
infancy, emerging evidence has implicated NR4A receptors in the
transcriptional control of proliferation, differentiation, survival,
and inﬂammation [5]. Based on this evidence, characterizing the
molecular mechanisms underlying inducible expression of NR4A
receptors is critical for understanding their functional role in the
transcriptional control of gene expression.In vascular biology, we and others have previously character-
ized NOR1 as a mitogenic transcription factor [6,7]. NOR1-deﬁ-
ciency limits aberrant vascular smooth muscle cell (SMC)
proliferation, decreases pathological neointima formation in
response to vascular injury, and reduces atherosclerosis formation
in mice [8,9]. In SMC, mitogen-induced NOR1 expression occurs
rapidly, leading to a more than 600-fold increase in transcript lev-
els [9]. This transient NOR1 expression is regulated by Ser133
phosphorylation of CREB and its subsequent recruitment to cAMP
response elements (CRE) in the NOR1 promoter [7]. The rapid
kinetics underlying the induction of several immediate-early
response genes are achieved by chromatin remodeling, including
histone acetylation [10]. Because histone acetylation is also critical
for the transcription of a variety of CREB target genes [11], we
investigated in the present study whether inhibition of histone
deacetylation activates NOR1 transcription. We provide direct
evidence that inhibition of histone deacetylation augments CREB
phosphorylation, increases histone acetylation and CREB
recruitment to the NOR1 promoter, and supports posttranslational
protein stability of NOR1.
2. Materials and methods
Materials and methods are available in the Supplementary data.
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3.1. NOR1 expression is induced by the HDAC inhibitor Scriptaid in
vascular SMC
To investigate the epigenetic regulation of NOR1 expression by
histone acetylation, we employed the HDAC inhibitor Scriptaid.
Scriptaid is a hydroxamic acid-containing HDAC inhibitor and has
been reported to increase histone acetylation with low cytotoxicity
[12]. Pre-treatment of rat aortic SMC (RASMC) with Scriptaid (2 lg/
ml) potentiated NOR1 mRNA and protein expression in response to
PDGF (25 ng/ml). This effect was more apparent at the later time
point after PDGF stimulation (Fig. 1A and B). Scriptaid alone also
induced NOR1 mRNA expression in quiescent RASMC, although
this induction was modest compared to co-stimulation with PDGF
(Fig. 1A and C).A 
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Fig. 1. The HDAC inhibitor Scriptaid induces NOR1 expression in SMC. (A–B) Quiesc
subsequently stimulated with PDGF (25 ng/ml). NOR1 mRNA (A) and protein expression (
with Scriptaid (2 lg/ml) or DMSO for 0.5, 2, 6, 12 and 24 h for NOR1 mRNA analyses.
increase over untreated (UT) cells (⁄P < 0.05 vs. unstimulated () in panel A; #P < 0.05 vs.
loading. The autoradiograms shown are representative of three independently performe3.2. HDAC depletion increases PDGF-induced NOR1 mRNA expression
In order to identify selective HDACs that regulate NOR1 mRNA
expression, RASMC were transiently transfected with siRNA
against HDAC1, HDAC2 and HDAC3 followed by PDGF stimulation.
As depicted in Fig. 2A, siRNA mediated depletion of HDAC1-3 was
conﬁrmed by quantitative RT-PCR. Primarily, depletion of HDAC3
enhanced both basal and inducible NOR1 mRNA expression follow-
ing PDGF stimulation (Fig. 2B). In contrast, selective knock-down of
HDAC1 or HDAC2 did not exhibit an overt effect on basal NOR1
transcription or NOR1 mRNA expression at 2 h. However, depletion
of HDAC1 moderately increased NOR1 transcript at the analyzed
6 h time-point. These ﬁndings conﬁrm that both non-selective
pharmacological HDAC inhibition and selective depletion of pre-
dominantly HDAC3 enhance basal and mitogen-induced NOR1
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ent RASMC were pretreated with Scriptaid (2 lg/ml) or DMSO for 30 min, and
B) were analyzed at the indicated time points. (C) Quiescent RASMC were stimulated
mRNA expression was normalized to RPL13A and expressed as mean ± S.E.M. fold
DMSO in panel A and C). Immunoblotting for GAPDH was performed to assess equal
d experiments.
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Fig. 2. siRNA-mediated knockdown of HDAC3 expression increases PDGF-induced
NOR1 mRNA expression. (A–B) RASMC were transiently transfected with HDAC1,
HDAC2, HDAC3 or scrambled (scr) siRNA (50 nM) for 6 h, and further cultured
overnight. Transfected cells were starved in 0.01% FBS in DMEM for 48 h and
stimulated with PDGF (25 ng/ml) or vehicle (PBS) for 2 or 6 h as indicated for mRNA
analyses. The expression of HDAC1, HDAC2, HDAC3 and NOR1 was normalized to
RPL13A and expressed as mean ± S.E.M. fold increase over scr-siRNA-transfected
vehicle-treated cells (⁄P < 0.05 vs. vehicle, #P < 0.05 vs. scr-siRNA).
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Fig. 3. Scriptaid increases NOR1 promoter activity without affecting NOR1
transcript stability. (A) RASMC were transiently transfected with a luciferase
reporter construct (2 lg) driven by a 1.7 kb NOR1 promoter fragment and
stimulated with DMSO or Scriptaid (2 lg/ml) overnight. Protein lysate was
collected and analyzed for luciferase activity. Data were normalized to Renilla
luciferase activity and presented as mean ± S.E.M. from three independently
performed experiments (⁄P < 0.05 vs. DMSO). (B) Quiescent RASMC (UT, untreated
control) were pretreated with Scriptaid (2 lg/ml) or DMSO for 30 min and
subsequently stimulated with PDGF (25 ng/ml) for 2 h. Actinomycin D (10 lg/ml)
was added to inhibit transcription, and mRNA was collected at the indicated time
points. NOR1 mRNA expression was normalized to RPL13A in three independent
experiments. Data are expressed as mean ± S.E.M. relative to samples stimulated
with PDGF for 2 h without actinomycin. N.S. indicates that no statistical signiﬁcance
was detected between DMSO and Scriptaid treatments.
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NOR1 transcript stability
mRNA accumulation results from the net effect of de novo tran-
scription as well as transcript stabilization. To further understandthe mechanism by which NOR1 mRNA is induced in response to
HDAC inhibition, we next analyzed NOR1 promoter activity in
SMC. Using transient transfection of a luciferase reporter driven
by the NOR1 promoter sequence, we ﬁrst documented that
Scriptaid induced NOR1 promoter activation in RASMC (Fig. 3A).
This activation was potent and occurred even in the absence of
mitogenic stimulation, indicating that HDAC inhibition alone is
sufﬁcient to increase NOR1 transcription. We next evaluated the
alternative induction of NOR1 transcript levels by HDAC inhibition
through a potential stabilization of NOR1 mRNA. RASMC were pre-
treated with Scriptaid and stimulated with PDGF for 2 h to induce
NOR1 mRNA accumulation, followed by the addition of actinomy-
cin D (10 lg/ml) to inhibit mRNA transcription. As depicted in
Fig. 3B, chase experiments revealed that Scriptaid did not affect
NOR1 transcript stability. In summary, these two experiments
demonstrate that Scriptaid increases NOR1 mRNA expression by
activating de novo NOR1 transcription.
3.4. Scriptaid enhances CREB phosphorylation and its recruitment to
the NOR1 promoter
CREB Ser133 phosphorylation and its recruitment to CRE motifs
within the NOR1 promoter mediate NOR1 transcriptional
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Fig. 4. Scriptaid enhances CREB phosphorylation and the recruitment of phospho-CREB to its binding sites in the NOR1 promoter. (A) Quiescent RASMC were pretreated with
Scriptaid (2 lg/ml) or DMSO for 30 min and subsequently stimulated with PDGF (25 ng/ml) for 0.5, 1 and 3 h for protein analyses. Immunoblotting for total CREB was
performed to assess equal loading. The autoradiograms are representative of three independently performed experiments. Densitometric quantiﬁcation is provided in the
lower panel (⁄P < 0.05 vs. DMSO). (B–C) Quiescent RASMC were pretreated with Scriptaid (2 lg/ml) or DMSO for 30 min and subsequently stimulated with PDGF (25 ng/ml)
for 1 h for ChIP assays. Chromatin complexes were immunoprecipitated with antibodies against phospho-S133 CREB, AcH3K9, and species-matched IgG. PCR products were
ampliﬁed using primers covering the CRE sites from 79 bp to 46 bp in the NOR1 promoter. The upper agarose gels shown are representative of three independently
performed experiments. The lower graphs depict quantiﬁcation of immunoprecipitated chromatin by real-time PCR. Cycle threshold (Ct) values were normalized to Ct values
of input samples and presented as mean ± S.E.M. fold increase over quiescent DMSO-treated samples, (⁄P < 0.05 vs. quiescent; #P < 0.05 vs. DMSO).
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by which Scriptaid activates NOR1 transcription, CREB phosphory-
lation was next analyzed. Interestingly, Scriptaid alone rapidly
induced CREB phosphorylation, although this effect was modest
compared to PDGF stimulation (Fig. 4A). Similarly, PDGF-induced
CREB phosphorylation was enhanced by Scriptaid at all time points
analyzed (Fig. 4A).
HDAC inhibition increases histone acetylation, and acetylated
histone H3 lysine 9 (AcH3K9) has been implicated in gene activa-
tion [13]. Therefore, we next speciﬁcally analyzed histone acetyla-
tion at CRE sites within the endogenous NOR1 promoter using ChIP
assays. As shown in Fig. 4B, PDGF stimulation induced histone H3
acetylation at the CRE motif in the NOR1 promoter. As expected,
inhibition of HDAC activity by Scriptaid alone increased histone
acetylation. This regulation of histone H3 acetylation was paral-
leled by the recruitment of Ser133-phosphorylated CREB to the
same CRE motif (Fig. 4C). Collectively, these data establish that
inhibition of HDAC activity induces histone acetylation, which is
sufﬁcient to facilitate binding of activated CREB to the CRE motif.3.5. The HDAC inhibitor Scriptaid increases NOR1 protein stability
In addition to epigenetic regulation of transcription, HDAC
inhibition induces posttranslational acetylation of nuclear recep-
tors, which supports nuclear receptor protein stability and induces
transcriptional activity [14]. To assess this possibility, RASMC were
treated with vehicle or Scriptaid, and PDGF-stimulated protein lev-
els were measured after inhibition of protein de novo synthesis
with cycloheximide (Fig. 5A). As shown in Fig. 5B, quantiﬁcation
of protein levels revealed that Scriptaid signiﬁcantly increased pro-
tein stability and half-life when compared to vehicle treatment.
Therefore, HDAC inhibition not only induces NOR1 expression by
generating permissive histone marks leading to increased tran-
scription but also through posttranslational protein stabilization.
4. Discussion
Data presented here characterize NOR1 as an immediate-early
response gene induced by histone acetylation in vascular cells.
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Fig. 5. The HDAC inhibitor Scriptaid increases NOR1 protein stability. (A–B) Quiescent RASMC were pretreated with Scriptaid (2 lg/ml) or DMSO for 30 min and subsequently
stimulated with PDGF (25 ng/ml) for 6 h. Cycloheximide (CHX, 10 lg/ml) was added to inhibit protein synthesis and protein was collected at the indicated time points. (A)
The autoradiograms are representative of three independently performed experiments. Immunoblotting for GAPDH was performed to assess equal loading. (B) Densitometric
quantiﬁcation of NOR1 expression was performed from three independent experiments and normalized to GAPDH expression. UT indicates quiescent cells. Results are
expressed as mean ± S.E.M. fold increase over samples stimulated with PDGF 6 h without cycloheximide; (⁄P < 0.05 vs. PDGF 6 h, #P < 0.05 vs. DMSO).
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tion factor in SMC, and its deﬁciency attenuates SMC proliferation,
atherosclerosis, and neointima formation [7,9]. This activity of
NOR1 as an effector of SMC proliferation is mediated by direct
binding to its consensus elements in target promoters, including
for example cyclin D and the S-phase-kinase-associated protein 2
[9,15]. Considering the rapid expression of NOR1, we sought to
investigate whether chromatin modiﬁcations orchestrate its tran-
sient induction and the ensuing transcriptional activity to induce
downstream target genes. In the present study, we demonstrate
that inhibition of HDAC activity induces the transcriptional pro-
gram underlying mitogen-induced NOR1 expression in SMC. In
addition to this transcriptional mechanism of induction, HDAC
inhibition stabilizes NOR1 protein through posttranslational mod-
iﬁcation of the receptor.
Inducible histone acetylation precedes the transcription of
multiple immediate-early response genes [10]. To our knowledge,
our data are the ﬁrst to establish that pharmacological HDAC
inhibition activates both basal and inducible expression of the
immediate-early response gene NOR1 in SMC. Our observation of
histone hyperacetylation-dependent NOR1 transcription in SMC
is consistent with two prior studies, which identiﬁed increased
NOR1 expression in response to treatment with HDAC inhibitors
in hippocampal [16] and myeloid leukemia cells [17]. However,
the regulation of NOR1 by HDAC inhibition remains controversial,
since NOR1 expression has also been reported to be suppressed by
the HDAC inhibitor trichostatin A in pheochromocytoma cells [18].
Therefore, these studies, along with our data, support the concept
that NOR1 is regulated through distinct transcriptional mecha-
nisms, which are likely both stimulus- and tissue-dependent.
Albeit these discrepant observations, the molecular mecha-
nisms utilized by histone acetylation to regulate transcriptionfactor-dependent NOR1 expression have not been investigated.
Using siRNA technology, our experiments ﬁrst indicated that pri-
marily HDAC3 depletion activates NOR1 transcription in SMC. As
mentioned previously, inducible NOR1 transcription in SMC is
mediated by CREB binding to its responsive elements, which is
activated following mitogen-induced Ser133 phosphorylation [7].
Interestingly, HDAC3 has been shown to repress CREB-dependent
transcription in recent studies [19], and our ChIP experiments con-
ﬁrm that inhibition of HDAC activity results in increased histone
acetylation and the subsequent recruitment of phosphorylated
CREB to its consensus sites within the NOR1 promoter. However,
in addition to this histone-dependent Ser133-phosphorylated
CREB recruitment to the NOR1 promoter, HDAC inhibition also
increased CREB phosphorylation in response to PDGF stimulation.
These data point to a second mechanism of regulation and indicate
that not only direct histone tail modiﬁcation constitutes a target
for HDAC-mediated repression of NOR1 but also the phosphoryla-
tion status of CREB itself. This notion is supported by previous data
demonstrating that HDAC inhibitors augment CREB activity by
altering the dephosphorylation of CREB [20]. Finally, many nuclear
receptors are subject to acetylation, which regulates their stability,
ligand sensitivity, and trans-activation potential [21]. Similarly, our
experiments revealed that HDAC inhibition enhances protein
stability of NOR1. These studies provide evidence for a third and
posttranslational mechanism regulating NOR1 expression in SMC,
in which HDAC deacetylates NOR1 to maintain NOR1 hypoacety-
lated leading to its rapid degradation. Collectively, our data illus-
trate three novel mechanisms of transcriptional (i.e. histone
deacetylation and dephosphorylation of CREB) and posttransla-
tional (i.e. protein degradation) regulation of NOR1, in which HDAC
function coordinately in SMC to repress NOR1 transcription and
facilitate its rapid degradation following mitogen stimulation.
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